Neil Aubuchon
Corporate Officer/Principal bei ABCELLERA BIOLOGICS INC.
Vermögen: 219 243 $ am 31.03.2024
Profil
Neil Aubuchon is currently the Chief Commercial Officer at AbCellera Biologics, Inc. Prior to this, he worked as the Global Marketing Lead-General Medicine at Amgen, Inc., Vice President-Global Marketing at Santen, Inc., Chief Marketing Officer at Eli Lilly Japan KK, and Chief Marketing Officer at Eli Lilly Australia Pty Ltd.
He holds an MBA from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2023 | 48 398 ( 0,02% ) | 219 243 $ | 31.03.2024 |
Aktive Positionen von Neil Aubuchon
| Unternehmen | Position | Beginn |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | 02.12.2021 |
Ehemalige bekannte Positionen von Neil Aubuchon
| Unternehmen | Position | Ende |
|---|---|---|
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The private company is based in Kobe, Japan. | Sales & Marketing | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Corporate Officer/Principal | - |
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly Australia Pty Ltd. manufactures and supplies pharmaceutical products. It develops medicines for diabetes, cancer, immunology, and pain. The company was founded in 1960 and is headquartered in West Ryde, Australia. | Sales & Marketing | - |
| AMGEN INC. | Sales & Marketing | - |
Ausbildung von Neil Aubuchon
| University of Toronto | Masters Business Admin |
| University of Western Ontario | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The private company is based in Kobe, Japan. | Health Technology |
Eli Lilly Australia Pty Ltd.
Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly Australia Pty Ltd. manufactures and supplies pharmaceutical products. It develops medicines for diabetes, cancer, immunology, and pain. The company was founded in 1960 and is headquartered in West Ryde, Australia. | Health Technology |
